CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions		Jun. 30, 2025	Dec. 31, 2024
Assets
Cash and cash equivalents	[1]	$ 1,435	$ 1,987
Accounts receivable, less allowance for doubtful accounts of $17 in 2025 and $18 in 2024		1,540	1,316
Inventories		2,439	2,306
Other current assets		509	377
Total current assets		5,923	5,986
Property, plant and equipment, less accumulated depreciation of $2,796 in 2025 and $2,635 in 2024		3,537	3,391
Operating lease right-of-use assets		302	219
Goodwill		2,758	2,724
Identifiable intangible assets, less accumulated amortization		1,075	1,127
Noncurrent deferred tax assets		617	540
Other noncurrent assets		267	250
Total assets		14,479	14,237
Liabilities and Equity
Current portion of long-term debt		1,350	1,350
Accounts payable		508	433
Dividends payable		222	224
Accrued expenses		770	746
Accrued compensation and related items		293	441
Income taxes payable		93	93
Other current liabilities		130	125
Total current liabilities		3,366	3,412
Long-term debt, net of discount and issuance costs		5,231	5,220
Noncurrent deferred tax liabilities		156	167
Operating lease liabilities		210	174
Other taxes payable		265	272
Other noncurrent liabilities		274	222
Total liabilities		9,502	9,467
Commitments and contingencies (Note 15)
Stockholders’ equity:
Common stock, $0.01 par value: 6,000,000,000 authorized; 501,891,243 and 501,891,243 shares issued; 443,945,593 and 448,743,073 shares outstanding at June 30, 2025, and December 31, 2024, respectively		5	5
Treasury stock, at cost, 57,945,650 and 53,418,170 shares of common stock at June 30, 2025 and December 31, 2024, respectively		(8,226)	(7,445)
Additional paid-in capital		1,203	1,182
Retained earnings		12,872	11,968
Accumulated other comprehensive loss		(877)	(940)
Total Zoetis Inc. equity		4,977	4,770
Equity attributable to noncontrolling interests		0	0
Total equity		4,977	4,770
Total liabilities and equity		$ 14,479	$ 14,237

[1] As of June 30, 2025 and December 31, 2024, includes $0 million and $2 million of restricted cash, respectively.